CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.
Saved in:
| Title: | CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. |
|---|---|
| Authors: | Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York., Geyer SM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Nixon AB; Duke Cancer Institute, Duke University Health System, Durham, North Carolina., Innocenti F; University of North Carolina, Chapel Hill, North Carolina., Shi Q; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Kumthekar P; Alliance for Clinical Trials in Oncology Protocol Office, Chicago, Illinois., Jacobson S; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., El Dika I; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York., Yaqubie A; Memorial Sloan Kettering Cancer Center, New York, New York., Lopez J; Memorial Sloan Kettering Cancer Center, New York, New York., Huang B; Memorial Sloan Kettering Cancer Center, New York, New York., Tang YW; Memorial Sloan Kettering Cancer Center, New York, New York., Wen Y; University of Chicago, Chicago, Illinois., Schwartz LH; Columbia University Medical Center, New York, New York.; New York-Presbyterian Hospital, New York, New York., El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, California., Knox JJ; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Rajdev L; Lenox Hill Hospital, New York, New York., Bertagnolli MM; Brigham and Women's Hospital, Boston, Massachusetts., Meyerhardt JA; Dana-Farber/Partners Cancer Care, Boston, Massachusetts., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York., Venook AP; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. |
| Source: | Cancer research communications [Cancer Res Commun] 2024 Mar 07; Vol. 4 (3), pp. 682-690. |
| Publication Type: | Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
